南宁眼角双眼皮费用(南宁微创三点双眼皮) (今日更新中)

BEIJING, Sept. 26 (Xinhuanet) -- Although it is home to traditional Chinese medicine (TCM), China must do much more to improve its academic research capacity for acupuncture, a form of TCM, to take the lead worldwide on both the academic and clinical sides.At present, among all academic theses on acupuncture indexed by the Science Citation Index (SCI), a leading world thesis index system, only 5 percent are from the Chinese mainland, according to Wang Linpeng, the director of the acupuncture and moxibustion center of the Beijing Hospital of Traditional Chinese Medicine, which is affiliated with the Capital Medical University.Although Chinese acupuncturists absolutely excel worldwide in clinical practice, "they are not as good as their foreign peers in academic capacity, particularly Western-style research methods and lab experiment design," he told China Daily on Friday during the 2011 International Symposium on Acupuncture. A patient suffering from facial paralysis receives acupuncture treatment at a hospital in Nanjing, the capital of Jiangsu province, on Dec 6, 2010.Studies by TCM practitioners - including acupuncturists - largely focus on their area of specialization, and few are in line with global interest in the medical science that has been proven effective over thousands of years, he said."Chinese TCM practitioners are very good at treating conditions, but they are clumsy at showing how and why it really works in an internationally accepted 'language' and 'manner'," said Gao Sihua, chancellor of the Beijing University of Chinese Medicine."It's especially true in TCM circles, where few Chinese practitioners would regularly follow international academic articles and research trends," Wang said.Measured by the number of articles on acupuncture indexed by SCI, the US and European countries lead globally, he said.

SAN FRANCISCO, Aug. 23 (Xinhua) -- The amount of malware targeted at devices based on Google's Android platform surged 76 percent in the second quarter over the previous three months in 2011, making it the most attacked mobile operating system, computer security firm McAfee said on Tuesday.A new McAfee study found that in the second quarter, Android- based malware surpassed Nokia's Symbian as the most popular target for mobile malware developers.While Symbian and Java ME, a platform designed for mobile devices and other embedded systems, remain the most targeted to date, the rapid rise in Android malware indicates that the platform could become an increasing target for cyber criminals McAfee said.Models pose with the new Samsung Galaxy S Android smartphone during its launch ceremony at the headquarters of Samsung Electronics in Seoul in this June 8, 2010 file photograph.It warned that the attacks on Android platform could affect everything from calendar apps, to text messages, and even a fake Angry Birds updates.According to the study, malware on mobile platforms is increasing steadily, often mimicking the same code as personal computer-based threats, as vast amount of personal and business data are now found on user's smartphones and other mobile devices."This year we've seen record-breaking numbers of malware, especially on mobile devices, where the uptick is in direct correlation to popularity," Vincent Weafer, senior vice president of McAfee Labs, said in a statement."Overall attacks are becoming more stealth and more sophisticated, suggesting that we could see attacks that remain unnoticed for longer periods of time," he noted.

BEIJING, Sep. 13 (Xinhuanet) --Experts have called for a national drug-control system after a nationwide deficit of a life-saving drug, which has lasted at least three months.Doctors at a Beijing hospital said some specialized hospitals, which perform hundreds of cardiac operations every month, have been paralyzed by their lack of protamine sulfate, which is commonly administered after heart surgery to reverse the anticoagulant effects of heparin.The earliest report of a shortage was in Hubei province on July 21. This was followed by reports of shortages in Guangdong, Shandong and Liaoning provinces.The Shandong newspaper, Qilu Evening News, quoted a regional sales manager, surnamed Zhuang, as saying the province had been allocated 150 doses of protamine sulfate after Shanghai No 1 Biochemical and Pharmaceutical Co Ltd recently resumed production of the drug."But its monthly use here is usually 10,000 doses," he said.The Ministry of Health has denied it is responsible for supplies of the drug and passed the buck to the State Food and Drug Administration, claiming the latter is responsible for the supervision of medicines.Shen Chen, head of the publicity office of the State Food and Drug Administration, said he was unaware of the shortage, but said the administration is responsible for the quality of medicines, not the supply."Development and reform authorities oversee the medicines' prices, while the industrial and commercial authorities oversee the storage. The food and drug departments only cover the approval and quality of medicines."Industry insiders said one of the reasons for the shortage was the low profit margin, which discourages companies from mass producing the drug."Some companies can't earn enough to recover their costs, therefore it is almost impossible to maintain their enthusiasm for continuing production," said Lu Guoping, secretary-general of the Shanghai Pharmaceutical Trade Association.Lu said the government should issue policies to prevent future shortages of such medicines to avoid possible nationwide public health incidents.Yi Shenghua, a lawyer at Beijing Yingke Law Firm, said the country should have a unified system to guarantee the normal supply of medicines that are widely used and drug manufacturers should fulfill their responsibilities to society, even though there is no law stipulating they should produce specific medicines.He came up with two ways to deal with the problem of companies only producing profitable drugs."The government can order businesses to manufacture a certain amount of cheap medicines. Or it can offer financial assistance to subsidize cheap, but life-saving medicines."

SHANGHAI, July 19 (Xinhua) -- Baidu Inc., the largest Chinese search engine based in Beijing, said Tuesday it closed a deal that allows the company to provide download services of music from Universal Music, Warner Music and Sony Music.According to the deal signed between Baidu and One Stop China (OSC), a joint venture of the three music companies, Baidu will pay them on a per-play and per-download basis for all tracks delivered through its MP3 server, said a press release provided by Baidu.Users can have access to the authorized music free of charge, and Chinese songs, both in Mandarin and Cantonese, and some global content provided by the three music companies will be included in the catalogue.Baidu also launched a social music platform called "Baidu ting!" through which users can obtain and share some music-related information and content.Li Xinzhe, CFO of Baidu, described the deal as a "milestone" that can benefit not only Baidu and its partners but also music lovers and the privacy-stricken industry.Wang Bin, secretary general of Copyright Union of Internet Society of China, predicted that it would have a demonstrative effect on the Internet sector.In 2008, Universal, Warner and Sony Music sued Baidu for at least 63.5 million yuan (9.8 million U.S. dollars) in copyright infringement.

SYDNEY, Aug. 5 (Xinhua) -- The Western Australian Government announced on Friday that 14 new substances linked to the manufacture of the synthetic drug Kronic would be banned from Friday midnight.The State Mental Health Minister Helen Morton told the Australian Broadcasting Corporation (ABC) Radio on Friday morning that two substances found in Kronic Black would be banned from midnight tonight (Friday night), as well as another 12 others found in synthetic cannabis products.People caught in possession of banned synthetic cannabis face hefty fines or possible jail sentences.The government of Western Australia (WA) in June listed a number of synthetic cannabis products, including Kronic, Voodoo and Mango Kush, as illegal substances.But synthetic drug makers have since released a new product, Kronic Black Label, using a different blend of chemicals they say make it still legal to sell.Police suspect the death of a 38-year-old Perth man is linked to his smoking of the synthetic cannabis product Kronic Black Label, which contains two of the 14 substances to be banned.The man, from Hillman in Perth's south, was rushed to Rockingham Hospital on Thursday night after suffering a suspected cardiac arrest, but he later died.Police now are conducting an investigation to identify the cause of the man's death.The Australian Medical Association has warned that synthetic drugs could cause severe paranoia, anxiety and panic attacks.

来源：资阳报